Skip to content

Released Aug 11, 2020, after the close

10-Q filed Aug 12, 2020, 43 days after period end · 0001636422-20-000069

Q2 2020 · 10-Q
Revenue$43.26M+17.5% vs Q2 2019−4.1% vs Q1 2020
Net Income-$27.18MN/M vs Q2 2019N/M vs Q1 2020
EPS Diluted-$0.71N/M vs Q2 2019N/M vs Q1 2020
Operating Income-$15,640,000N/M
Operating Cash Flowderived-$751,000N/M
Free Cash Flowderived-$1,112,000N/M
Margins · derived
Operating margin-36.2%−10.7 pt vs Q2 2019
Net margin-62.8%−33.8 pt vs Q2 2019

What the release said

The release

Same quarter

MetricQ2 2020Q2 2019Q2 2018
Revenue$43.26M$36.80M$22.99M
Net Income-$27.18M-$10.69M-$19.32M
EPS Diluted-$0.71-$21.98-$3.53

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR